Expression of MiR-335 and its target metalloproteinase genes: clinical significance in breast cancer
- 10 January 2020
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 128 (3) , 569-575
Abstract
Background: Early diagnosis of breast cancer decreases mortality rate; therefore, novel diagnostic methods are urgently required. In this study, authors aimed to investigate the role of serum-derived miR-335 in breast cancer, and the expression of matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (MMP9) and evaluating their feasibility and clinical utility as biomarkers for the early detection of breast cancer. Materials and methods: Blood samples were collected from a total of 210 individuals who were enrolled in this study. The participants were divided into newly diagnosed breast cancer patients (n = 115), patients with benign breast lesions (n =55) and healthy individuals as control group (n =40). The expression profile of miR-335, MMP2 and MMP9 were determined using quantitative polymerase chain reaction (qPCR). Results: MiR 335 expression level was down-regulated in primary breast cancer group as compared to benign breast group and healthy individuals with 98% and 94.9% sensitivity and specificity, respectively. MMP2 and MMP9 showed significantly higher expression levels in breast cancer group as compared to both benign and healthy group and reporting 92.7% and 93% sensitivity, respectively. The relations between investigated markers and pathologic types, staging, grading, and lymph node involvement were significant with these factors. Expression level of miR-335 was decreased with increased MMP2 and MMP9 at significant level. Conclusion: MiR-335, MMP2, and MMP9 can be used as diagnostic markers in breast cancer.Keywords
Funding Information
- Science and Technology Development Fund (15089)
This publication has 23 references indexed in Scilit:
- MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerGenes & Development, 2011
- miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cellsCell Death & Differentiation, 2010
- Matrix Metalloproteinases and Angiogenic FactorsThe American Journal of Pathology, 2010
- Matrix metalloproteinase‐9 is associated with disease‐free survival and overall survival in patients with gastric cancerInternational Journal of Cancer, 2010
- Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasionClinical & Experimental Metastasis, 2009
- The Staging of Cancer: A Retrospective and Prospective AppraisalCA: A Cancer Journal for Clinicians, 2008
- Oncogenes and CancerNew England Journal of Medicine, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001